A groundbreaking approach led by a team of scientists, including Rice University chemist James Tour, has the potential to ...
Discover new treatments currently being developed for pancreatic cancer, which has historically been extremely difficult to ...
Pancreatic cancer is one of the deadliest of all cancers. Only 12% of men diagnosed with pancreatic cancer are alive five ...
A novel approach developed by scientists, including Rice University chemist James Tour, could transform treatment for ...
It is difficult to treat once the cancer has spread, as it cannot be removed completely with surgery. Now researchers from the University of Copenhagen and Rigshospitalet have made significant ...
A phase 2a trial of IMM-1-104 plus chemotherapy demonstrated efficacy and tolerability in first- and second-line pancreatic ...
Adding pamrevlumab to standard chemotherapy did not improve survival in patients with locally advanced pancreatic cancer ...
PALM BEACH, Fla., Jan. 22, 2025 (GLOBE NEWSWIRE) -- FN Media Group News Commentary - The demand for effective pancreatic cancer treatments is and has been undeniably high. The growing number of ...
SAN FRANCISCO -- Older patients' survival in metastatic pancreatic cancer had a significant association with baseline ...
Alexander I. Spira, MD, PhD, FACP, discusses the clinical implications of ctDNA for treatment decisions and monitoring in ...